CD40LG and cancer: Furthermore, other research showed T. gondii IgG antibodies in 114 (45.2%) cancer patients were positive, and T. gondii IgM+ antibodies were 26 (10.3%) as well as 17 (6.7%) of specimens had both IgG and IgM antibodies.